Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3679-3679
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 288-288
Open Access | Times Cited: 24
Predictive value of the nutritional risk index for postoperative complications in individuals with pancreatic cancer undergoing pancreaticoduodenectomy
W. Ye, Jin Wang, Jie Zheng, et al.
Geriatric Nursing (2025) Vol. 61, pp. 605-612
Closed Access
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone, Camilla Pecoraro, Giovanna Panzeca, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 412-412
Open Access | Times Cited: 19
Marine Streptomyces-Derived Novel Alkaloids Discovered in the Past Decade
Zijun Liu, Wenyan Sun, Zhe Hu, et al.
Marine Drugs (2024) Vol. 22, Iss. 1, pp. 51-51
Open Access | Times Cited: 4
Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities
Yiyang Li, Zhizhong Xie, Xiaoyong Lei, et al.
Bioorganic Chemistry (2024), pp. 107160-107160
Closed Access | Times Cited: 3
Synthesis and biological activity of 11-Oxygenated and heterocyclic estrone analogs in pancreatic cancer monolayers and 3D spheroids
Khaled Alseud, Trevor Ostlund, Mikhail Durymanov, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117678-117678
Closed Access | Times Cited: 3
Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic adenocarcinoma
Ida Boček, Leentje Persoons, Dirk Daelemans, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131239-131239
Closed Access | Times Cited: 3
Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules
Davide Bassani, Neil Parrott, Nenad Manevski, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 683-698
Open Access | Times Cited: 3
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy
Olamide Tosin Olaoba, Temitope Isaac Adelusi, Ming Yang, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1808-1808
Open Access | Times Cited: 2
Identification of Biomarkers Associated with Oxidative Stress and Immune Cells in Acute Pancreatitis
Yuan Xu, Jie Song, Jie Gao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4077-4091
Open Access | Times Cited: 2
Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation
Lin‐Ling Gan, Ying Yang, Zizhen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116008-116008
Closed Access | Times Cited: 7
Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development
Galina I. Buravchenko, Andrey E. Shchekotikhin
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1174-1174
Open Access | Times Cited: 5
Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties
Anja Beč, Leentje Persoons, Dirk Daelemans, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107326-107326
Closed Access | Times Cited: 1
Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro
Bahar Cepni, Thomas Tessonnier, Ivana Đokić, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1497-1497
Open Access | Times Cited: 1
Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy
Wenyan She, Tingting Liu, Haimei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14683-14699
Closed Access | Times Cited: 4
Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development
Camilla Pecoraro, Francesca Terrana, Giovanna Panzeca, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6450-6450
Open Access | Times Cited: 4
Circ_0002395 promotes aerobic glycolysis and proliferation in pancreatic adenocarcinoma cells via miR-548c-3p/PDK1 axis
Meng-lu Shu, Jun-kai Xia, Jing Yan, et al.
Journal of Bioenergetics and Biomembranes (2023) Vol. 56, Iss. 1, pp. 55-71
Closed Access | Times Cited: 3
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
Maria Chiara Scaini, Luisa Piccin, Davide Bassani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12285-12285
Open Access | Times Cited: 2
Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity
Thoraya A. Farghaly, Ghada S. Masaret, Hanan Gaber Abdulwahab
Polycyclic aromatic compounds (2024), pp. 1-16
Closed Access
Bis-pyrazole as receptor interacting protein 1 kinase inhibitor: Synthesis, preliminary biological evaluation against pancreatic cancer cell line and its docking studies
Sandeep Singh, Rajeev Sharma, R. Ramajayam
Results in Chemistry (2024) Vol. 7, pp. 101447-101447
Open Access
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma
Xiaofeng Sun, Hao Song, Xiaoran Sun, et al.
Cancer Investigation (2024) Vol. 42, Iss. 3, pp. 226-242
Open Access
Synthesis of novel triazole-urea hybrids and their antiproliferative activity against pancreatic cancer through suppression of eEF2K and induction of apoptosis
Aslı Türe, Burcu Özdemir, Onur Çeçe, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138428-138428
Closed Access
AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET
Z Chen, Pengbiao Miao, Hongcao Lin, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 431-444
Open Access
5-NITRO-THIOPHENE-THIOSEMICARBAZONE DERIVATIVE INDUCES CELL DEATH, CELL CYCLE ARREST, AND PHOSPHO-KINASE SHUTDOWN IN PANCREATIC DUCTAL ADENOCARCINOMA CELLS
Valécia de Cássia Mendonça da Costa, Maria do Carmo Alves de Lima, Iranildo José da Cruz Filho, et al.
European Journal of Pharmacology (2024), pp. 176963-176963
Closed Access
Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry
Yi Chen, Liu-yan Li, Jian‐Di Li, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top